Michael Potente
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Sirtuins and Resveratrol in Medicine 5
- Aging 2
- Co-authors
- Peter CarmelietHolger GerhardtStefanie DimmelerAndreas M. ZeiherTaija MäkinenIngrid FlemingRudi BusseBeate Fißlthaler
- Journals
- Nature Communications (5 papers)Nature (5 papers)Circulation Research (3 papers)eLife (3 papers)Nature Cell Biology (2 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Michael Potente
55 papers receiving 9.7k citations
Hit Papers
Peers
Comparison fields: 5 of 136
- Cancer Research 2.5k
- Geriatrics and Gerontology 589
- Biochemistry 966
- Molecular Biology 6.0k
- Cell Biology 1.1k
Countries citing papers authored by Michael Potente
This map shows the geographic impact of Michael Potente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Potente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Potente more than expected).
Fields of papers citing papers by Michael Potente
This network shows the impact of papers produced by Michael Potente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Potente. The network helps show where Michael Potente may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Potente, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 2 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 5 | |
| 6 | Inhibition of fatty acid oxidation enables heart regeneration in adult mice Hit paper breakdown → | 2023 | 136 |
| 7 | 2022 | 11 | |
| 8 | 2021 | 69 | |
| 9 | 2021 | 27 | |
| 10 | 2021 | 53 | |
| 11 | 2020 | 90 | |
| 12 | 2018 | 6 | |
| 13 | 2013 | 44 | |
| 14 | 2013 | 41 | |
| 15 | Basic and Therapeutic Aspects of Angiogenesis Hit paper breakdown → | 2011 | 2129 |
| 16 | MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice Hit paper breakdown → | 2009 | 987 |
| 17 | 2009 | 279 | |
| 18 | SIRT1 controls endothelial angiogenic functions during vascular growth Hit paper breakdown → | 2007 | 508 |
| 19 | 2005 | 140 | |
| 20 | 2005 | 435 |
About Michael Potente
Michael Potente is a scholar working on Geriatrics and Gerontology, Aging, Cancer Research, Biochemistry and Cell Biology, having authored 55 papers that have together received 9.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (10 papers), Cancer-related molecular mechanisms research (9 papers), Hippo pathway signaling and YAP/TAZ (8 papers), FOXO transcription factor regulation (7 papers), Congenital heart defects research (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Sirtuins and Resveratrol in Medicine (5 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Cancer Research (2.5k citations), Geriatrics and Gerontology (589 citations), Biochemistry (966 citations), Molecular Biology (6.0k citations) and Cell Biology (1.1k citations). Michael Potente has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Peter Carmeliet, Holger Gerhardt, Stefanie Dimmeler, Andreas M. Zeiher, Taija Mäkinen, Ingrid Fleming, Rudi Busse, Beate Fißlthaler, Carmen Urbich and Marina Mione. Their work appears in journals such as Nature Communications, Nature, Circulation Research, eLife and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.